Expertise in
2
conditions

Dr. Bradley A. Marder

Nephrology
Office
1601 E 19th Ave Ste 4300, 
Denver, CO 
Expertise in
2
conditions
Office
1601 E 19th Ave Ste 4300, 
Denver, CO 

Overview

Bradley Marder is a Nephrologist practicing medicine in Denver, Colorado.

Dr. Marder is highly rated in 2 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Nephrosclerosis, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 4 clinical trials.

Specialties

Nephrology

Licenses

Internal Medicine in CO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
1601 E 19th Ave Ste 4300, Denver, CO 80218

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy
A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drugs: Sparsentan, Irbesartan
Study Phase: Phase 3
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
Enrollment Status: Completed
Publish Date: April 17, 2026
Intervention Type: Drug
Study Drugs: Sparsentan, Irbesartan
Study Phase: Phase 3
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

3 Total Publications

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.
Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.
Journal: Transplantation direct
Published: September 06, 2022
Similar Doctors
Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (7.0 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michel Chonchol is a Nephrologist practicing medicine in Aurora, Colorado. Dr. Chonchol is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Kidney Transplant. Dr. Chonchol is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (7.0 miles away)
720-848-0749
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Isaac Teitelbaum is a Nephrologist practicing medicine in Aurora, Colorado. Dr. Teitelbaum is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Secondary Peritonitis, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and High Potassium Level. Dr. Teitelbaum is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (7.0 miles away)
720-848-0749
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joshua Thurman is a Nephrologist practicing medicine in Aurora, Colorado. Dr. Thurman is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Glomerulonephritis, Properdin Deficiency, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant. Dr. Thurman is currently accepting new patients.

Frequently Asked Questions about Dr. Bradley A. Marder

How do I make an appointment with Dr. Bradley A. Marder?

You can book an appointment with Dr. Bradley A. Marder by calling their office at 303-861-4845. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bradley A. Marder a top-rated expert for End-Stage Renal Disease (ESRD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bradley A. Marder is classified as an Advanced expert for End-Stage Renal Disease (ESRD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bradley A. Marder specialize in?

While Dr. Bradley A. Marder is a Nephrology, they have specific expertise in End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Nephrosclerosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nephrology.

Does Dr. Bradley A. Marder participate in research or clinical trials?

Yes. Dr. Bradley A. Marder has published 3 articles and abstracts on conditions like End-Stage Renal Disease (ESRD). You can view a list of Dr. Bradley A. Marder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Marder's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile